SNPred outperforms other ensemble-based SNV pathogenicity predictors and elucidates the challenges of using ClinVar for evaluation of variant classification quality

Ivan Molotkov, Daniel C. Koboldt, Mykyta Artomov
doi: https://doi.org/10.1101/2023.09.07.23295192

Article Information

doi 
https://doi.org/10.1101/2023.09.07.23295192
History 
  • September 11, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Ivan Molotkov1,2,
  2. Daniel C. Koboldt1,2 and
  3. Mykyta Artomov1,2,*
  1. 1The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children’s Hospital, Columbus, OH, 43215
  2. 2Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, 43205
  1. ↵*Correspondence: Mykyta.Artomov{at}nationwidechildrens.org
Back to top
Posted September 11, 2023.
Download PDF

Supplementary Material

Data/Code
Email
SNPred outperforms other ensemble-based SNV pathogenicity predictors and elucidates the challenges of using ClinVar for evaluation of variant classification quality
Ivan Molotkov, Daniel C. Koboldt, Mykyta Artomov
medRxiv 2023.09.07.23295192; doi: https://doi.org/10.1101/2023.09.07.23295192
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area